Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 426 - 450 of 955 in total
Investigational
Matched Synonyms: … Stat3 inhibitor tti-101
Matched Name: … TTI-101
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Synonyms: … DYN 101
Matched Name: … DYN-101
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis).
Investigational
Matched Synonyms: … AMY 101
Matched Name: … AMY-101
Matched Description: … AMY-101 in Adults With Gingivitis). ... AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. ... AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement Inhibitor …
LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements.
Investigational
Matched Name: … LAX-101
Matched Description: … LAX-101 treats hungtington’s disease, not just the symptoms but the disease itself. ... The active molecule in LAX-101 is Eicosapentaenoic Acid (EPA). All molecules of EPA are identical. ... The molecules of EPA found in LAX-101 are identical to the molecules of EPA found in fish oil food supplements …
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
Matched Name: … AP-101
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
Investigational
Matched Name: … YA-101
AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene.
Investigational
Matched Name: … AVB-101
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
Investigational
Matched Name: … EVT-101
Investigational
Matched Name: … PHI-101
AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human Dok-7 protein. It is under investigation for the treatment of Dok-7-associated myasthenia.
Investigational
Matched Name: … AMP-101
Matched Description: … AMP-101 is a gene therapy comprising an adeno-associated virus type 9 (AAV9) vector encoding the human …
CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.
Investigational
Matched Name: … CUDC-101
Matched Description: … CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer …
ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D)
Investigational
Matched Name: … ATSN-101
Matched Description: … ATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5 …
CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
Investigational
Matched Name: … CYNK-101
Matched Description: … CYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy …
ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. ST101 has been used in trials studying the treatment of Essential Tremor and Alzheimer's Disease.
Investigational
Matched Synonyms: … ST-101 (D-AMINO ACID PEPTIDE) …
Matched Name: … ST-101
Matched Description: … ST-101 is a small peptide antagonist of C/EBPβ and T-type calcium channel activator. …
Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma. Biomed 101 is a solid. Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity.
Investigational
Matched Name: … Biomed 101
Matched Description: … Biomed 101 is a solid. ... Biomed 101 is investigated for use/treatment in adverse effects (chemotherapy) and renal cell carcinoma ... Biomed 101 binds to the leukotriene B4 receptor, but does not affect interleukin-2 antitumor activity …
AV-101 has been used in trials studying the treatment of Neuropathic Pain.
Investigational
Matched Name: … AV-101
Matched Description: … AV-101 has been used in trials studying the treatment of Neuropathic Pain. …
INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein.
Investigational
Matched Name: … INBRX-101
Matched Description: … INBRX-101 is a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein. …
GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety conjugated with human immunoglobulin G4 Fc.
Investigational
Matched Name: … GI-101
Matched Description: … GI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation …
Investigational
Matched Name: … SP-101
Investigational
Matched Name: … CM-101
FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
Investigational
Matched Name: … FBX-101
Matched Description: … FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase …
NGN-101 is an adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 gene
Investigational
Matched Name: … NGN-101
Matched Description: … NGN-101 is an adeno-associated virus serotype 9 vector with engineered transgene encoding the human CLN5 …
MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy intended to treat Canavan disease. Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. It is caused by a mutation in the aspartoacylase gene (ASPA), which leads to a deficiency of the...
Investigational
Matched Name: … MYR-101
Matched Description: … MYR-101 targets oligodendrocytes and delivers functional ASPA. ... MYR-101 (rAAV-Olig001-ASPA) is a recombinant adeno-associated virus (rAAV) vector-based gene therapy ... [L43567] The FDA has granted MYR-101 Fast Track, Rare Pediatric Disease (RPD), and Orphan Drug designations …
Investigational
Matched Name: … SUN-101
Investigational
Matched Name: … TSHA-101
Displaying drugs 426 - 450 of 955 in total